Rotstein DL - Search Results

1

A Canadian case control study investigating demographic and environmental factors associated with MOGAD.

Hosseini-Moghaddam S, Marrie RA, Wolfson C, Carruthers R, Freedman MS, Morrow S, Lee L, Nisenbaum R, Konig A, Magalhaes S, Rotstein DL. Hosseini-Moghaddam S, et al. Among authors: rotstein dl. Mult Scler Relat Disord. 2023 Nov;79:105023. doi: 10.1016/j.msard.2023.105023. Epub 2023 Sep 27. Mult Scler Relat Disord. 2023. PMID: 37804766

2

Multiple sclerosis fatigue is associated with reduced psychomotor vigilance.

Rotstein D, O'Connor P, Lee L, Murray BJ. Rotstein D, et al. Can J Neurol Sci. 2012 Mar;39(2):180-4. doi: 10.1017/s0317167100013196. Can J Neurol Sci. 2012. PMID: 22343150

3

An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.

Carruthers RL, Rotstein DL, Healy BC, Chitnis T, Weiner HL, Buckle GJ. Carruthers RL, et al. Among authors: rotstein dl. Mult Scler. 2014 Sep;20(10):1381-90. doi: 10.1177/1352458514535282. Epub 2014 May 22. Mult Scler. 2014. PMID: 24852928

4

Temporal trends in multiple sclerosis prevalence and incidence in a large population.

Rotstein DL, Chen H, Wilton AS, Kwong JC, Marrie RA, Gozdyra P, Krysko KM, Kopp A, Copes R, Tu K. Rotstein DL, et al. Neurology. 2018 Apr 17;90(16):e1435-e1441. doi: 10.1212/WNL.0000000000005331. Epub 2018 Mar 16. Neurology. 2018. PMID: 29549225

5

MS risk in immigrants in the McDonald era: A population-based study in Ontario, Canada.

Rotstein DL, Marrie RA, Maxwell C, Gandhi S, Schultz SE, Fung K, Tu K. Rotstein DL, et al. Neurology. 2019 Dec 10;93(24):e2203-e2215. doi: 10.1212/WNL.0000000000008611. Epub 2019 Nov 5. Neurology. 2019. PMID: 31690681 Free PMC article.

6

Evaluation of ethnicity as a predictor of diagnostic phenotype and prognosis in neuromyelitis optica spectrum disorder in Toronto, Canada.

Stratos K, Lee L, Dai D, Pavenski K, Zuo F, Rotstein D. Stratos K, et al. Mult Scler Relat Disord. 2020 May;40:101950. doi: 10.1016/j.msard.2020.101950. Epub 2020 Jan 14. Mult Scler Relat Disord. 2020. PMID: 31982662

7

Risk of Mortality in Immigrants with Multiple Sclerosis in Ontario, Canada.

Rotstein D, Maxwell C, Tu K, Schultz SE, Fung K, Marrie RA. Rotstein D, et al. Neuroepidemiology. 2020;54(2):148-156. doi: 10.1159/000506161. Epub 2020 Feb 5. Neuroepidemiology. 2020. PMID: 32023615

8

Health service utilization in immigrants with multiple sclerosis.

Rotstein DL, Marrie RA, Tu K, Schultz SE, Fung K, Maxwell CJ. Rotstein DL, et al. PLoS One. 2020 Jul 9;15(7):e0234876. doi: 10.1371/journal.pone.0234876. eCollection 2020. PLoS One. 2020. PMID: 32645017 Free PMC article.

9

Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations.

Freedman MS, Devonshire V, Duquette P, Giacomini PS, Giuliani F, Levin MC, Montalban X, Morrow SA, Oh J, Rotstein D, Yeh EA; Canadian MS Working Group. Freedman MS, et al. Can J Neurol Sci. 2020 Jul;47(4):437-455. doi: 10.1017/cjn.2020.66. Epub 2020 Apr 6. Can J Neurol Sci. 2020. PMID: 32654681 Review.

10

High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis.

Rotstein D, Maxwell C, Tu K, Gatley J, Pequeno P, Kopp A, Marrie RA. Rotstein D, et al. Mult Scler. 2021 Oct;27(12):1902-1913. doi: 10.1177/13524585211031791. Epub 2021 Jul 30. Mult Scler. 2021. PMID: 34328821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters